Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae.
第一作者:
Ryan K,Shields
第一单位:
Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA Antibiotic Management Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA XDR Pathogen Laboratory, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
作者:
主题词
抗菌药(Anti-Bacterial Agents);氮杂双环化合物(Azabicyclo Compounds);细菌蛋白质类(Bacterial Proteins);头孢他啶(Ceftazidime);复方合剂(Drug Combinations);肺炎克雷伯菌(Klebsiella pneumoniae);微生物敏感性试验(Microbial Sensitivity Tests);突变(Mutation);孔蛋白质类(Porins);β-内酰胺酶类(beta-Lactamases)
DOI
10.1128/AAC.00548-15
PMID
26169413
发布时间
2024-03-25
- 浏览16
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文